We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Portable Biosensor Platform to Reduce Hospital-Acquired Infections

By HospiMedica International staff writers
Posted on 11 Oct 2024

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections, making them a significant cause of mortality. More...

Microorganisms contracted in hospitals are frequently resistant to many common antibiotics. By 2050, the number of deaths caused by drug-resistant infections is projected to rise to 10 million worldwide, posing a serious public health challenge. Early detection of nosocomial infections and effective disinfection of hospitals and healthcare facilities are crucial to reducing these numbers, but current methods have limitations. Researchers are now developing a bio-based disinfectant to eliminate key pathogens responsible for HAIs, integrated into a new, flexible, and portable biosensor platform.

The biosensor platform being developed by a collaborative team of researchers, including from AIMPLAS - Plastics Technology Centre (Valencia, Spain;) under the NOSOSENS Project, uses printed electrochemical sensors for rapid, selective detection of Staphylococcus aureus, a methicillin-resistant bacterium responsible for 11% of nosocomial infections. The standard method currently used in hospitals to prevent these infections involves pathogen detection through cell culture microscopy, with results typically available in four to five days. The NOSOSENS portable electrochemical biosensor platform, however, offers immediate, specific detection and quantification of bacteria from the Staphylococcus aureus family. The system will also feature data monitoring, management, and alert capabilities.

A key challenge with current cleaning products is that pathogens' antimicrobial resistance renders many disinfectants less effective. Stronger disinfectants, such as peracetic acid, are often required, but they can cause long-term surface damage and are unsuitable for daily use in healthcare settings. The NOSOSENS solution, however, is both highly biocidal and bio-based, making it biodegradable, less aggressive, and more environmentally friendly. The innovations will be tested using a portable, user-friendly system for early bacterial detection by healthcare personnel, alongside an effective and sustainable pathogen elimination system for surgical tools and surfaces. By integrating with the sensor platform, this system will optimize disinfection processes, improving safety against hospital-acquired infections. It will also enable rapid tracing, control, and elimination of surface colonization, reducing risks associated with hospital stays.

Related Links:
AIMPLAS


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Xenon Light Source
CLV-S400
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.